Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more In a CES 2025 keynote speech by Nvidia CEO ...
In a significant step towards regulating and scaling artificial intelligence in public healthcare, Union Health Minister ...
MammaPrint and BluePrint testing identify HR+/HER2- breast cancer patients who benefit from anthracycline-based chemotherapy. The FLEX Study showed MammaPrint High Risk 2 and BluePrint Luminal B ...
IRVINE, California, Oct. 6, 2020 /PRNewswire/ -- Agendia Inc., a world leader in precision oncology for breast cancer, announced today the availability of local testing for its CE-marked MammaPrint® ...
ZURICH (Reuters) - Roche has struck a $1.7 billion cancer drug pact with Blueprint Medicines , it said on Tuesday, as advances in genetic testing for rare mutations drive lucrative deals for expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results